Tumor suppressor p53 functions as a negative regulator in IgE-mediated mast cell activation

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Suzuki, Kotaro ^a,b   Murphy, Samantha H ^a   Xia, Yifeng ^a   Yokota, Masaya ^b   Nakagomi, Daiki ^b   Liu, Fei ^a   Verma, Inder M ^a   Nakajima, Hiroshi ^b  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B KINASE BETA; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E RECEPTOR; INTERLEUKIN 6; PROTEIN P53; TUMOR NECROSIS FACTOR ALPHA; I KAPPA B KINASE; TRANSCRIPTION FACTOR RELA;

ALLERGIC REACTION; ANAPHYLAXIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CATALYSIS; CELL ACTIVATION; CONTROLLED STUDY; ENZYME ACTIVITY; GLYCOSYLATION; MAST CELL; MAST CELL DEGRANULATION; MOUSE; NONHUMAN; PROTEIN FUNCTION; UPREGULATION; ANIMAL; CELL CULTURE; FLOW CYTOMETRY; GENETICS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; METABOLISM; MOUSE MUTANT; POLYMERASE CHAIN REACTION;

MUS;

ANIMALS; CELLS, CULTURED; FLOW CYTOMETRY; GLYCOSYLATION; I-KAPPA B KINASE; IMMUNOBLOTTING; IMMUNOGLOBULIN E; IMMUNOPRECIPITATION; MAST CELLS; MICE; MICE, MUTANT STRAINS; POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTOR RELA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 80053118349     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0025412     Document Type: Article

References (30)

1. Galli SJ, Nakae S, Tsai M, (2005) Mast cells in the development of adaptive immune responses. Nat Immunol 6: 135-142.
2. Galli SJ, Kalesnikoff J, Grimbaldeston MA, Piliponsky AM, Williams CM, et al. (2005) Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu Rev Immunol 23: 749-786.
3. Hayden MS, Ghosh S, (2004) Signaling to NF-κB. Genes Dev 18: 2195-2224.
4. Li Q, Verma IM, (2002) NF-κB regulation in the immune system. Nat Rev Immunol 2: 725-734.
5. Scheidereit C, (2006) IκB kinase complexes: gateways to NF-κB activation and transcription. Oncogene 25: 6685-6705.
6. Perkins ND, (2007) Integrating cell-signaling pathways with NF-κB and IKK function. Nat Rev Mol Cell Biol 8: 49-62.
7. Suzuki K, Verma IM, (2008) Phosphorylation of SNAP-23 by IκB kinase 2 regulates mast cell degranulation. Cell 134: 485-495.
8. Vogelstein B, Lane D, Levine AJ, (2000) Surfing the p53 network. Nature 408: 307-310.
9. Riley T, Sonag E, Chen P, Levine A, (2008) Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol 9: 402-412.
10. Green DR, Kroemer G, (2009) Cytoplasmic functions of the tumour suppressor p53. Nature 458: 1127-1130.
11. Vousden KH, Prives C, (2009) Blinded by the light: The growing complexity of p53. Cell 137: 413-431.
12. Kruse J-P, Gu W, (2009) Modes of p53 regulation. Cell 137: 609-622.
13. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA Jr, et al. (1992) Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356: 215-221.
14. Beg AA, Sha WC, Bronson RT, Ghosh S, Baltimore D, (1995) Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature 376: 167-170.
15. Suzuki K, Nakajima H, Ikeda K, Maezawa Y, Suto A, et al. (2003) IL-4-Stat6 signaling induces tristetraprolin expression and inhibits TNF-alpha production in mast cells. J Exp Med 198: 1717-1727.
16. Nagashima K, Sasseville VG, Wen D, Bielecki A, Yang H, et al. (2006) Rapid TNFR1-dependent lymphocyte depletion in vivo with a selective chemical inhibitor of IKKβ. Blood 107: 4266-4273.
17. Tergaonkar V, Correa RC, Ikawa M, Verma IM, (2005) Distinct roles of IκB proteins in regulating constitutive NF-κB activity. Nat Cell Biol 7: 921-923.
18. Xia Y, Padre RC, De Mendoza TH, Bottero V, Tergaonkar VB, et al. (2008) Phosphorylation of p53 by IκB kinase 2 promotes its degradation by β-TrCP. Proc Natl Acad Sci 106: 2629-2634.
19. Sigala JLD, Bottero V, Young DB, Shevchenko A, Mercurio F, et al. (2004) Activation of transcription factor NF-κB requires ELKS, an IκB kinase regulatory subunit. Science 304: 1963-1967.
20. Suzuki K, Nakajima H, Kagami S, Suto A, Ikeda K, et al. (2002) Proteolytic processing of Stat6 signaling in mast cells as a negative regulatory mechanism. J Exp Med 196: 27-38.
21. Hepp R, Puri N, Hohenstein AC, Crawford GL, Whiteheart SW, et al. (2005) Phosphorylation of SNAP-23 regulates exocytosis from mast cells. J Biol Chem 280: 6610-6620.
22. Liu G, Park Y-J, Tsuruta Y, Lorne E, Abraham E, (2009) p53 attenuates lipopolysaccharide-induced NF-κB activation and acute lung injury. J Immunol 182: 5063-5071.
23. Vassilev LT, Vu BT, Graves B, Carvajal D, Podlaski F, et al. (2004) In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science 303: 844-848.
24. Polyak K, Waldman T, He TC, Kinzler KW, Vogelstein B, (1996) Genetic determinants of p53-induced apoptosis and growth arrest. Genes Dev 10: 1945-1952.
25. Bensaad K, Tsuruta A, Selak MA, Vidal MN, Nakano K, et al. (2006) TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 126: 107-120.
26. Villunger A, Michalak EM, Coultas L, Mullauer F, Bock G, et al. (2003) p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa. Science 302: 1036-1038.
27. Greten FR, Arkan MC, Bollrath J, Hsu LC, Goode J, et al. (2007) NF-κB is a negative regulator of IL-1β secretion as revealed by genetic and pharmacological inhibition of IKKβ. Cell 130: 918-931.
28. Kawauchi K, Araki K, Tobiume K, Tanaka N, (2008) p53 regulates glucose metabolism through an IKK-NF-κB pathway and inhibits cell transformation. Nat Cell Biol 10: 611-618.
29. Kawauchi K, Araki K, Tobiume K, Tanaka N, (2009) Loss of p53 enhances catalytic activity of IKKβ through O-linked β-N-acetyl glucosamine modification. Proc Natl Acad Sci USA 106: 3431-3436.
30. Ogawa S, Lozach J, Benner C, Pascual G, Tangirala RK, et al. (2005) Molecular determinants of crosstalk between nuclear receptors and toll-like receptors. Cell 122: 707-721.